Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease
Introduction Nontuberculous pulmonary disease causes significant morbidity and mortality. Efforts to tackle infections are hampered by the lack of reliable biomarkers for diagnosis, assessment and prognostication. The aim of this study was to develop molecular assays capable of identifying and quant...
Main Authors: | Huw C. Ellis, Miriam F. Moffatt, Colin Churchward, Leah Cuthbertson, William O.C. Cookson, Michael R. Loebinger |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2023-03-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/9/2/00435-2022.full |
Similar Items
-
The Changing Pattern of Nontuberculous Mycobacterial Disease
by: Joseph O Falkinham
Published: (2003-01-01) -
Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan
by: Ping Wang, et al.
Published: (2024-07-01) -
Nonpharmacological Treatment for Nontuberculous Mycobacterial Pulmonary Disease
by: Hyung-Jun Kim
Published: (2024-10-01) -
The lung microbiota in nontuberculous mycobacterial pulmonary disease.
by: Bo-Guen Kim, et al.
Published: (2023-01-01) -
Clinico-microbiological Profile of Nontuberculous Mycobacterial Keratitis
by: Richa Dhiman, et al.
Published: (2022-05-01)